We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$150M
AUM Growth
-$19.5M
Cap. Flow
-$10.6M
Cap. Flow %
-7.05%
Top 10 Hldgs %
52.92%
Holding
99
New
9
Increased
16
Reduced
55
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.62M
2
LLY icon
Eli Lilly
LLY
+$1.28M
3
HCAT icon
Health Catalyst
HCAT
+$1.27M
4
PRVA icon
Privia Health
PRVA
+$1.03M
5
CLOV icon
Clover Health Investments
CLOV
+$983K

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$1.46M
3
ICLR icon
Icon
ICLR
+$1.32M
4
EW icon
Edwards Lifesciences
EW
+$1.26M
5
OPCH icon
Option Care Health
OPCH
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 99.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SWTX
76
DELISTED
SpringWorks Therapeutics
SWTX
$199K 0.13%
5,500
-4,510
-45% -$158K
VTRS icon
77
Viatris
VTRS
$20.5B
$194K 0.13%
15,600
-10,040
-39% -$123K
NVO
78
Novo Nordisk
NVO
$208B
$189K 0.13%
2,200
– –
RPRX icon
79
Royalty Pharma
RPRX
$25.3B
$184K 0.12%
7,200
-9,230
-56% -$245K
MRNA icon
80
Moderna
MRNA
$21.9B
$181K 0.12%
4,350
-9,610
-69% -$459K
MDGL icon
81
Madrigal Pharmaceuticals
MDGL
$11.1B
$176K 0.12%
570
-475
-45% -$134K
INCY icon
82
Incyte
INCY
$24B
$173K 0.12%
+2,500
New +$178K
CRGX
83
DELISTED
CARGO Therapeutics
CRGX
$123K 0.08%
+8,500
New +$154K
EXEL icon
84
Exelixis
EXEL
$13.8B
$117K 0.08%
3,500
-7,510
-68% -$244K
AXSM icon
85
Axsome Therapeutics
AXSM
$10.9B
$69.4K 0.05%
+820
New +$75.4K
IOBT
86
DELISTED
IO Biotech
IOBT
$69K 0.05%
+75,000
New +$74.6K
ADCT icon
87
ADC Therapeutics
ADCT
$134M
– –
-36,214
Closed -$114K
APLS
88
DELISTED
Apellis Pharmaceuticals
APLS
– –
-10,300
Closed -$297K
CATX icon
89
Perspective Therapeutics
CATX
$343M
– –
-20,400
Closed -$272K
DXCM icon
90
DexCom
DXCM
$33B
– –
-10,700
Closed -$717K
EVH icon
91
Evolent Health
EVH
$353M
– –
-39,000
Closed -$1.1M
GDRX icon
92
GoodRx Holdings
GDRX
$1.07B
– –
-116,000
Closed -$805K
ICLR icon
93
Icon
ICLR
$12.2B
– –
-4,608
Closed -$1.32M
IQV icon
94
IQVIA
IQV
$38.4B
– –
-7,600
Closed -$1.8M
ITOS
95
DELISTED
iTeos Therapeutics
ITOS
– –
-15,650
Closed -$160K
JPST icon
96
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
– –
-2,500
Closed -$127K
OPCH icon
97
Option Care Health
OPCH
$3.55B
– –
-40,000
Closed -$1.25M
ZBH icon
98
Zimmer Biomet
ZBH
$18.8B
– –
-13,500
Closed -$1.46M
KYTX icon
99
Kyverna Therapeutics
KYTX
$455M
– –
-22,900
Closed -$112K
1 2 3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return
BIS
BG Investment Services Hagatna, Guam $120M AUM 17.44% 1-Year Est. Return

Sectoral Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sectoral Asset Management held 99 positions worth $150M, down 12% from $169M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management withdrew a net $10.6M in Q4 2024, closing 13 positions and reducing 55 holdings. Its most notable exit was IQVIA, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in Health Catalyst worth $1.13M.

  • Sectoral Asset Management's largest Q4 2024 buy was Health Catalyst: 160,000 shares worth $1.13M.
  • Sectoral Asset Management added most to Amgen in Q4 2024, an estimated $1.62M increase.
  • Sectoral Asset Management's biggest Q4 2024 reduction was Edwards Lifesciences, cutting an estimated $1.26M.
  • Sectoral Asset Management fully exited IQVIA in Q4 2024, selling an estimated $1.8M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $150M portfolio in Q4 2024.
  • Sectoral Asset Management opened 9 new positions and closed 13 in Q4 2024.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $150M.

Based on Sectoral Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.